首页> 外国专利> THERAPEUTIC DOSE RADIOMARKETING WITH RHENIUM-188 AND AUTOMATION THEREOF, IN PARTICULAR FOR THE TREATMENT OF LIVER CANCER

THERAPEUTIC DOSE RADIOMARKETING WITH RHENIUM-188 AND AUTOMATION THEREOF, IN PARTICULAR FOR THE TREATMENT OF LIVER CANCER

机译:R188进行放射性剂量的放射治疗及其自动化,特别是用于肝癌的治疗

摘要

A composition for the treatment of liver cancer comprising a complex of the following formula: [M (SCR 3) 2 (SCR 2)] (I) wherein M is the high-activity 188Re, and a lipophilic organic phase. R represents an alkyl, cycloalkyl, aralkyl or aryl group, unsubstituted or substituted by one or more substituents selected from halogen atoms, hydroxyl group, alkyl groups and alkoxy groups.
机译:一种用于治疗肝癌的组合物,其包含下式的配合物:[M(SCR 3)2(SCR 2)](I)其中,M为高活性188Re,和亲脂性有机相。 R代表未被取代或被一个或多个选自卤素原子,羟基,烷基和烷氧基的取代基取代的烷基,环烷基,芳烷基或芳基。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号